Article
Anti-osteopontin antibodies replicate the tumor suppression phenotype in thrombin cleavage-resistant osteopontin knock-in mice.
Journal of thrombosis and haemostasis : JTH - 1 Nov 2025
Zhou Qin, Zhao Lei, Myles Timothy, Morser John, Leung Lawrence L K
Abstract excerpt
BACKGROUND: The multifunctional proinflammatory matricellular protein, osteopontin (OPN), is a prognostic marker in multiple human cancers. OPN is cleaved by thrombin to reveal a cryptic binding site for α4β1 and α9β1 integrins at the C-terminus of the N-terminal cleaved fragment (OPN-R). Preventing thrombin cleavage of full-length OPN (OPN-FL) improves outcomes in tumor models. OBJECTIVE: Test if anti-OPN...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
